Zogenix Reviews

Rating Trends
Recommend to a friend
Approve of CEO
Zogenix CEO and Director Roger L. Hawley
Roger L. Hawley
8 Ratings
  • A company with their heart in the right place

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee
    Neutral Outlook
    Approves of CEO


    Despite a challenging market and limited resources, Zogenix, culturally is a great place. Expectations are high to deliver but loyalty is rewarded and overall, the people are exceptional.


    The company is in a very challenging market, struggling with revenue and profitability. Experience is key and the ability to work independently and know what needs to be accomplished.

    Advice to Management

    Don't let the market dictate efforts and don't chase unicorns. Some folks are of more value than others and keeping the others around does not help the business.

Zogenix Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Accepted Offer
    Positive Experience
    Average Interview


    I applied through an employee referral. The process took 4 weeks. I interviewed at Zogenix.


    Typical pharmaceutical sales interview. Asked about past experience and roles and responsibilities. Why did you leave and what did like best about your past positions. What would be your first steps if you got the job and write a 30,60,90 day plan. Who was your best manager and why..

    Interview Questions

Zogenix Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.zogenix.com
Headquarters San Diego, CA
Size 51 to 200 Employees
Founded Unknown
Type Company - Public (ZGNX)
Industry Biotech & Pharmaceuticals
Revenue $25 to $50 million (USD) per year

Zogenix wants to help the pain go away faster. The biopharmaceutical company is developing and commercializing central nervous system (CNS) and therapeutic pain medications. The company's sole marketed product, Sumavel DosePro received FDA approval for in 2009. The drug combines the company's DosePro needle-free drug delivery technology with migraine drug sumatriptan. Patients can self-administer the drug subcutaneously for rapid relief of acute migraines and cluster headaches. Its late-stage candidate, ZX002, is an oral controlled-release formulation of ... More

Work at Zogenix? Share Your Experiences


Click to Rate